Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flare and Remission in Atopic Dermatitis with Cyclosporine A
NCT03710044Phase 4Withdrawn
- Sponsor
- LEO Pharma
- Start
- Jan 2019
- Primary completion
- Aug 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in atopic dermatitis (AD), sponsored by LEO Pharma. Planned start Jan 2019; status: withdrawn.
02
Drugs
cyclosporine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03710044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03710044.